Inflammation and cancer: back to Virchow?

@article{Balkwill2001InflammationAC,
  title={Inflammation and cancer: back to Virchow?},
  author={Frances R Balkwill and Alberto Mantovani},
  journal={The Lancet},
  year={2001},
  volume={357},
  pages={539-545}
}
The response of the body to a cancer is not a unique mechanism but has many parallels with inflammation and wound healing. This article reviews the links between cancer and inflammation and discusses the implications of these links for cancer prevention and treatment. We suggest that the inflammatory cells and cytokines found in tumours are more likely to contribute to tumour growth, progression, and immunosuppression than they are to mount an effective host antitumour response. Moreover cancer… Expand

Paper Mentions

Interventional Clinical Trial
The investigators compare the recurrence rate difference between two years after transurethral resection of the bladder tumor according to the method of anesthesia. Anesthetic… Expand
ConditionsBladder Cancer
InterventionDrug, Procedure
Observational Patient Registry Clinical Trial
This study is a case controlled analytical study that analyzes the relationship between levels of inflammatory markers with the type of brain tumor. Samples of 35 people were then… Expand
ConditionsBrain Tumor
InterventionDiagnostic Test
Interventional Clinical Trial
Thyroid surgery is the most common surgical procedure among endocrine surgeries. It is performed in patients with suspected malignancy, patients diagnosed with malignancy, and for… Expand
ConditionsDelta Neutrophyl Index, Immature Granulocyte Count, Neutrophyl to Lymphocyte Ratio, (+3 more)
InterventionDiagnostic Test
News Article
Inflammation and cancer: a comparative view.
  • W. Morrison
  • Medicine
  • Journal of veterinary internal medicine
  • 2012
TLDR
Chronic inflammation and associated reactive free radical overload and some types of bacterial, viral, and parasite infections that cause inflammation were recognized as important risk factors for cancer development and account for one in four of all human cancers worldwide. Expand
Inflammation and cancer: is AID aiding?
TLDR
Evidence is provided supporting the role of activation-induced cytidine deaminase (AID) as a link between inflammation and ulcerative colitis-associated colorectal cancer and a number of components including cytokines, chemokines, inducible nitric oxide synthase (NOS2), reactive nitrogen (RNS) and oxygen species (ROS) are implicated. Expand
The Links between Inflammation and Cancer
TLDR
Chronic inflammation is a crucial function of the innate immune system that protects against pathogens and initiates specific immunity and population-based studies link inflammatory disease or non-steroidal anti-inflammatory drug use with risk of some cancers. Expand
Interplay between inflammation and cancer.
TLDR
A deeper understanding of common pathways implicated between both the inflammation and cancer may pave the way to fight against both of these deleterious ailments. Expand
Cancer and inflammation
  • L. Munn
  • Biology, Medicine
  • Wiley interdisciplinary reviews. Systems biology and medicine
  • 2017
TLDR
How the innate and adaptive immune systems cooperate to neutralize pathogens and repair damaged tissues is still an area of intense investigation, and how these systems can respond to cancer, which arises from normal ‘self’ cells that undergo an oncogenic transformation, has profound implications for cancer therapy. Expand
Analysis of the intricate relationship between chronic inflammation and cancer.
TLDR
The present review outlines the various molecular and cellular inflammatory mediators responsible for tumour initiation, progression and development, and discusses the critical role of chronic inflammation in tumorigenesis. Expand
Inflammation in the context of oral cancer.
TLDR
The purpose of this article is to elaborate on some of the more important relationships between oral cancer and inflammation, and to comment on the role of inflammation in the pathogenesis of oral squamous cell carcinoma. Expand
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
TLDR
Clinical and experimental studies delineating protumorigenic roles for immune cell subsets that are players in cancer-associated inflammation are discussed, leading to resolution, or at least neutralization, of cancer-promoting chronic inflammation, thereby facilitating cancer rejection. Expand
Tumor-associated macrophages in cancer-related inflammation
TLDR
Inflammation is a key component of the tumor microenvironment and key orchestrators at the intersection of the intrinsic and extrinsic pathway include transcription factors, cytokines, and chemokines. Expand
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.
TLDR
The role of TAM in the inflammatory micro-environment of solid tumors is discussed and a potential target for future therapeutic approaches is identified. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease
TLDR
Diverse functions of TNF/TNFRs are placed into context with the development of specific pathology in murine models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease to suggest that TNF may also directly promote or downregulate the adaptive immune response. Expand
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease.
TLDR
There is accumulating evidence that long-term treatment with cyclo-oxygenase inhibitors, cytokines such as interferon-alpha, anti-oestrogens (tamoxifen and raloxifene) and captopril significantly reduces the incidence of solid tumours such as breast and colorectal cancer. Expand
Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.
TLDR
Results indicate that administration of pentoxifylline is an effective means of inhibiting acute TPA-induced cutaneous inflammation and pro-inflammatory cytokine gene expression, as well as is effective as an antipromoter that inhibits papilloma growth. Expand
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
TLDR
Evidence is provided that a pro-inflammatory cytokine is required for de novo carcinogenesis and that TNF-α is important to the early stages of tumor promotion and strategies that neutralize TNF–/– production may be useful in cancer treatment and prevention. Expand
Paradoxical effects of tumour necrosis factor in experimental ovarian cancer
TLDR
Recombinant human tumour necrosis factor (rhTNF) had anti‐tumour activity against 2 of 3 human ovarian cancer xenografts growing intraperitonealy in nude mice, producing a moderate increase in mouse survival time and promoting the adhesion of tumour cells to the peritoneum and their establishment as tumour nodules below the mesothelial surface. Expand
Cytokine regulation of endothelial cell function.
TLDR
The identification of cytokine circuits through which vascular cells participate to thrombotic, inflammatory, and immune reactions provides novel targets for therapeutic intervention. Expand
Tumor Necrosis Factor Sustains the Generalized Lymphoproliferative Disorder ( gld ) Phenotype
TLDR
It is concluded that TNF is necessary for the full manifestation of the lymphoproliferative disorder, in particularPlaying a critical role in lymphoaccumulation, which protects gld mice against premature death. Expand
Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.
TLDR
The coexpression of TNF and its receptor in ovarian cancer biopsies suggests the capacity for autocrine/paracrine action and TNF antagonists may have therapeutic potential in this malignancy. Expand
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
TLDR
It is shown that MCP-1-deficient mice are unable to mount TH2 responses and are resistant to Leishmania major, indicating that M CP-1 influences both innate immunity, through effects on monocytes, and adaptive immunity,through control of T helper cell polarization. Expand
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells.
TLDR
It is demonstrated that a weakly immunogenic tumor, the MCA 205 sarcoma, produces substantial amounts of murine monocyte chemoattractant protein 1 (MCP-1), which can have a potent inhibitory influence on the development of tumor-reactive T cells. Expand
...
1
2
3
4
5
...